Coya Therapeutics (COYA) Asset Utilization Ratio (2023 - 2026)
Coya Therapeutics (COYA) reported Asset Utilization Ratio of 0.15 for Q1 2026, up 72.71% on a YoY basis from 0.09 in Q1 2025, and down 20.63% sequentially from 0.19 in Q4 2025.
Coya Therapeutics (COYA) Asset Utilization Ratio (2023 - 2026) Analysis & Trends
Coya Therapeutics (COYA) has 4 years of Asset Utilization Ratio data on file, last reported at 0.15 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio rose 72.71% year-over-year to 0.15; the trailing twelve-month figure through Mar 2026 stood at 0.15 (up 72.71% YoY), and the FY2025 full-year result was 0.17, up 102.97% from the prior year.
- Asset Utilization Ratio eased to 0.15 in Q1 2026, from 0.19 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.25 in Q3 2024 to a low of 0.01 in Q2 2025.
- A 4-year average of 0.15 and a median of 0.15 in 2024 frame the typical range for Asset Utilization Ratio.
- Peak annual rise in Asset Utilization Ratio reached 117.86% in 2025, while the deepest fall reached 95.23% in 2025.
- Tracing COYA's Asset Utilization Ratio over 4 years: stood at 0.23 in 2023, then tumbled by 60.61% to 0.09 in 2024, then surged by 117.86% to 0.19 in 2025, then decreased by 20.63% to 0.15 in 2026.
- Business Quant data shows COYA's Asset Utilization Ratio at 0.15 in Q1 2026, 0.19 in Q4 2025, and 0.12 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 0.69 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Coya Therapeutics | 97.14 Mn | 46.42 Mn | - | 0.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.15 |
| Dec 31, 2025 | 0.19 |
| Sep 30, 2025 | 0.12 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.09 |
| Dec 31, 2024 | 0.09 |
| Sep 30, 2024 | 0.25 |
| Jun 30, 2024 | 0.25 |
| Mar 31, 2024 | 0.16 |
| Dec 31, 2023 | 0.23 |